Filing Details

Accession Number:
0000908662-13-000062
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-01-30 16:35:58
Reporting Period:
2013-01-29
Filing Date:
2013-01-30
Accepted Time:
2013-01-30 16:35:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1264587 Stemline Therapeutics Inc STML Pharmaceutical Preparations (2834) 450522567
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1209726 Kevin J Buchi C/O Stemline Therapeutics, Inc.
750 Lexington Avenue, 6Th Floor
New York NY 10022
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-01-29 500 $10.00 13,772 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The shares were purchased in the Issuer's initial public offering.